Veradigm Inc. Announces That Nasdaq Hearings Panel Has Granted Its Continued Listing, Pending Return To Compliance With Nasdaq Filing Requirements
Portfolio Pulse from Benzinga Newsdesk
Veradigm Inc. (MDRX) has been granted continued listing on the Nasdaq Capital Market by the Nasdaq Hearings Panel, conditional upon the company demonstrating compliance with Nasdaq Listing Rule 5250(c)(1) by February 27, 2024. Veradigm is currently noncompliant due to not filing its Annual Report for 2022 and Quarterly Reports for 2023. The company's stock remains listed on the Nasdaq Global Select Market and Veradigm intends to file the overdue reports as soon as possible.
December 13, 2023 | 9:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Veradigm Inc. has been granted conditional continued listing on Nasdaq, with a deadline of February 27, 2024, to comply with filing requirements. The company's stock remains listed and Veradigm is working to file overdue financial reports.
The news of continued listing is positive for Veradigm Inc. as it provides the company with additional time to meet Nasdaq's filing requirements, which may instill some confidence in investors. However, the company's inability to provide a definitive filing date for its financial reports introduces uncertainty, potentially limiting the positive impact on the stock price.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100